Immunic Inc (IMUX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Daniel Vitt
Employees:
70
1200 Avenue of the Americas Suite 200 New York, NY 10036
858-673-6840

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease.

Data derived from most recent annual or quarterly report
Market Cap 52.177 Million Shares Outstanding44.595 Million Avg 30-day Volume 466.191 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.51
Price to Revenue0.0 Debt to Equity0.0 EBITDA-129.575 Million
Price to Book Value1.6097 Operating Margin0.0 Enterprise Value34.233 Million
Current Ratio4.745 EPS Growth-0.17 Quick Ratio4.237
1 Yr BETA 2.386 52-week High/Low 3.17 / 0.95 Profit Margin0.0
Operating Cash Flow Growth12.2678 Free Cash Flow to Firm (FCFF) TTM -43.021 Million Free Cash Flow to Equity (FCFE) TTM-90.998 Million
Altman Z-Score-6.2416
View SEC Filings from IMUX instead.

View recent insider trading info

Immunic Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding IMUX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IMUX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-06-29 by RUDICK RICHARD ALAN
  • 4: filed on 2023-06-29 by NEERMANN JOERG
  • 4: filed on 2023-06-29 by TOERNSEN MONIKA MARIA
  • 4: filed on 2023-05-16 by WHALEY GLENN
  • 4: filed on 2023-04-27 by RUDICK RICHARD ALAN
  • 3: filed on 2023-04-27 by RUDICK RICHARD ALAN
  • 4: filed on 2022-12-15 by NEERMANN JOERG
  • 4: filed on 2022-11-25 by NEERMANN JOERG
  • 4: filed on 2022-11-23 by VITT DANIEL
  • 4: filed on 2022-11-08 by WHALEY GLENN

    • Events (8k)

  • 8-K: filed on 2023-11-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-18:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-10:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-30:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-04:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-05:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-13:
    Item 7.01: Regulation FD Disclosure

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HOWSON TAMAR D

    • Director
    		 0 2023-06-28 1

    PHILLIPS BARCLAY A

    • Director
    		 0 2023-06-28 1

    NEERMANN JOERG

    • Director
    		 0 2023-06-28 2

    TOERNSEN MONIKA MARIA

    • Director
    		 0 2023-06-28 1

    RUDICK RICHARD ALAN

    • Director
    		 0 2023-06-28 3

    WHALEY GLENN CHIEF FINANCIAL OFFICER

    • Officer
    		 25,510 2023-05-15 2

    NASH DUANE EXECUTIVE CHAIRMAN

    • Officer
    • Director
    		 132,000 2023-01-02 1

    VITT DANIEL CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 300,000 2023-01-02 1

    MUEHLER ANDREAS CHIEF MEDICAL OFFICER

    • Officer
    		 132,000 2023-01-02 1

    OSSIPOW VINCENT

    • Director
    		 10,000 2022-06-15 0

    VAN DEN BOSSCHE JAN

    • Director
    		 10,000 2022-06-15 0

    GROEPPEL MANFRED CHIEF OPERATING OFFICER

    • Officer
    		 45,000 2021-03-01 0

    PATEL SANJAY S CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2019-07-22 0

    GLOBAL LIFE BIOVENTURE V SARL

    OMEGA FUND V, L.P.

    OMEGA FUND V GP, L.P.

    OMEGA FUND V GP MANAGER, LTD.

    LIM RICHARD J.

    STAMPACCHIA OTELLO

    NESSI CLAUDIO

    PASTER ANNE-MARI

    • 10% Owner
    		 1,371,494 2019-04-12 0

    LSP V COOPERATIEVE U.A.

    LSP V MANAGEMENT B.V.

    • 10% Owner
    		 2,162,782 2019-04-12 0

    FUND N.V.

    • 10% Owner
    		 1,371,494 2019-04-12 0

    DUNN JOHN MICHAEL GENERAL COUNSEL AND SECRETARY

    • Officer
    		 0 2019-01-11 0

    COX RUSSELL J. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 0 2019-01-11 0

    ASHLEY ROBERT A. CHIEF SCIENTIFIC OFFICER, EVP

    • Officer
    		 0 2019-01-11 0

    SWANSON MICHAEL V. CHIEF FINANCIAL OFFICER, EVP

    • Officer
    		 0 2019-01-11 0

    HALPERIN ERROL R.

    • Director
    		 0 2018-09-25 0

    BIENAIME JEAN JACQUES

    • Director
    		 18,500 2018-09-24 0

    GODSHALL DOUGLAS EVAN

    • Director
    		 0 2018-09-19 0

    SATTER MUNEER A

    • Director
    • 10% Owner
    		 0 2018-09-13 0

    HASNAIN FAHEEM

    • Director
    		 8,000 2018-09-13 0

    COHEN CHERYL

    • Director
    		 0 2018-09-12 0

    STERN ARON CHIEF ADMINISTRATIVE OFFICER

    • Officer
    		 0 2018-07-01 0

    MURAWSKI RICHARD M VICE PRESIDENT, MANUFACTURING

    • Officer
    		 0 2018-06-09 0

    HENRY ANDREW VP, CLINICAL OPERATIONS

    • Officer
    		 0 2018-06-09 0

    SEARS LOWELL

    • Director
    		 0 2018-05-23 0

    MILLIS J. MICHAEL

    • Director
    		 0 2018-05-23 0

    WINTERS TERENCE E. CO-CHAIRMAN AND CEO

    • Officer
    • Director
    		 314,930 2017-06-14 0

    STEER RANDOLPH C

    • Director
    		 0 2017-05-23 0

    CROXFORD PHILIP M

    • Director
    		 0 2017-05-23 0

    LOEWEN ANDREA SEE REMARKS

    • Officer
    		 0 2016-05-13 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    IMMUNIC INC IMUX 2023-11-28 22:15:04 UTC 0.3989 4.9211 350000
    IMMUNIC INC IMUX 2023-11-28 21:45:03 UTC 0.3989 4.9211 350000
    IMMUNIC INC IMUX 2023-11-28 21:15:04 UTC 0.3989 4.9211 350000
    IMMUNIC INC IMUX 2023-11-28 20:45:04 UTC 0.3989 4.9211 350000
    IMMUNIC INC IMUX 2023-11-28 20:15:04 UTC 0.4 4.92 350000
    IMMUNIC INC IMUX 2023-11-28 19:45:03 UTC 0.4 4.92 350000
    IMMUNIC INC IMUX 2023-11-28 19:15:04 UTC 0.4 4.92 350000
    IMMUNIC INC IMUX 2023-11-28 18:45:03 UTC 0.4 4.92 350000
    IMMUNIC INC IMUX 2023-11-28 18:15:03 UTC 0.4 4.92 350000
    IMMUNIC INC IMUX 2023-11-28 17:45:04 UTC 0.4 4.92 350000
    IMMUNIC INC IMUX 2023-11-28 17:15:04 UTC 0.4 4.92 350000
    IMMUNIC INC IMUX 2023-11-28 16:45:04 UTC 0.4 4.92 350000
    IMMUNIC INC IMUX 2023-11-28 16:15:04 UTC 0.4 4.92 350000
    IMMUNIC INC IMUX 2023-11-28 15:45:03 UTC 0.4 4.92 350000
    IMMUNIC INC IMUX 2023-11-28 15:15:03 UTC 0.4 4.92 350000
    IMMUNIC INC IMUX 2023-11-28 14:45:04 UTC 0.3992 4.9208 350000
    IMMUNIC INC IMUX 2023-11-28 14:15:04 UTC 0.3992 4.9208 350000
    IMMUNIC INC IMUX 2023-11-28 13:45:04 UTC 0.3566 4.9634 350000
    IMMUNIC INC IMUX 2023-11-28 13:15:03 UTC 0.3566 4.9634 350000
    IMMUNIC INC IMUX 2023-11-28 12:45:04 UTC 0.3566 4.9634 300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    ADVISORS' INNER CIRCLE FUND II- Hancock Horizon Quantitative Long/Short Fund IMUX -23170.0 shares, $-284064.2 2021-06-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments